Nektar Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
CEOHoward W. Robin
CEOHoward W. Robin
Employees61
Employees61
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1990
Founded1990
Employees61
Employees61
NKTR Key Statistics
Market cap126.57M
Market cap126.57M
Price-Earnings ratio-1.08
Price-Earnings ratio-1.08
Dividend yield—
Dividend yield—
Average volume2.26M
Average volume2.26M
High today$0.71
High today$0.71
Low today$0.655
Low today$0.655
Open price$0.6839
Open price$0.6839
Volume1.43M
Volume1.43M
52 Week high$1.81
52 Week high$1.81
52 Week low$0.432
52 Week low$0.432
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
12.5%
Sell
12.5%
People also own
Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.